To investigate whether TBK1-mediated mitophagy might ameliorate MASH pathogenesis, we first assessed TBK1 expression and activation in liver tissues from MASLD mouse models. This evidence concerns the gene TBK1 and metabolic dysfunction-associated steatotic liver disease.